Last synced on 14 November 2025 at 11:06 pm

BOND Ready-to-Use Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16 (Concentrated Liquid Antibody Format).

Page Type
Cleared 510(K)
510(k) Number
K193393
510(k) Type
Traditional
Applicant
Leica Biosystems Newcastle Ltd.
Country
United Kingdom
FDA Decision
Substantially Equivalent
Decision Date
3/6/2020
Days to Decision
91 days
Submission Type
Summary

BOND Ready-to-Use Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16 (Concentrated Liquid Antibody Format).

Page Type
Cleared 510(K)
510(k) Number
K193393
510(k) Type
Traditional
Applicant
Leica Biosystems Newcastle Ltd.
Country
United Kingdom
FDA Decision
Substantially Equivalent
Decision Date
3/6/2020
Days to Decision
91 days
Submission Type
Summary